Frontiers in Oncology | Breast Cancer

Original Research

Published on 06 Apr 2023

Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer

in Breast Cancer

Wei Bin Fang
Marcela Medrano
Paige Cote
Mike Portsche
Vinamratha Rao
Yan Hong
Fariba Behbod
Jennifer R. Knapp
Clark Bloomer
Janelle Noel-Macdonnell

Frontiers in Oncology

doi 10.3389/fonc.2023.1130911

5,133 views
5 citations

Original Research

Published on 05 Apr 2023

Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis

in Breast Cancer

Si-qi Wu
Yan Liu
Jie Zhou
Yan-ting You
Xing-hong Zhou
Li-qian Chen
Hiu Yee Kwan
Xiao-shan Zhao
Yi-fen Wu
Yan-yan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1091249

3,848 views
2 citations

Original Research

Published on 03 Apr 2023

Axillary response and outcome in breast cancer patients after neoadjuvant treatment: The role of radiotherapy in reducing recurrence in ypN0 patients with initially cN+ stage

in Breast Cancer

Xiaoqiu Ren
Yaner Yu
Lihong Liu
Wenjie Xia
Runliang Ni
Shumei Wei
Jun Wu
Qichun Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1093155

2,250 views
2 citations

Original Research

Published on 31 Mar 2023

Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes

in Breast Cancer

Lifang Yuan
Jiannan Liu
Lei Bao
Huajun Qu
Jinyu Xiang
Ping Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1032364

7,099 views
17 citations

Original Research

Published on 31 Mar 2023

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer

in Breast Cancer

Ganglong Yang
Chenyang Zuo
Yuxiang Lin
Xiaoman Zhou
Piaopiao Wen
Chairui Zhang
Han Xiao
Meichen Jiang
Morihisa Fujita
Xiao-Dong Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1127446

4,233 views
10 citations

Original Research

Published on 31 Mar 2023

Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis

in Breast Cancer

Feng Jing
Zheng Zhu
Jiajia Qiu
Lichen Tang
Lei Xu
Weijie Xing
Yan Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1081786

7,829 views
28 citations

Original Research

Published on 31 Mar 2023

Comparative analysis of clinicopathological characteristics of central necrotizing breast cancer and basal cell-like breast cancer

in Breast Cancer

Li Ding
Wang Kun
Wenjing Xu
Shaohua Chen
Zhaogen Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.915949

2,556 views
1 citation

Original Research

Published on 30 Mar 2023

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3

in Breast Cancer

Bernardo L. Rapoport
Helen C. Steel
Carol A. Benn
Simon Nayler
Teresa Smit
Liezl Heyman
Annette J. Theron
Nomsa Hlatshwayo
Luyanda L.I. Kwofie
Pieter W.A. Meyer

Frontiers in Oncology

doi 10.3389/fonc.2023.1097309

4,125 views
12 citations

Systematic Review

Published on 29 Mar 2023

The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis

in Breast Cancer

Le Ma
Heyan Chen
Jianjun He
Peiling Xie
Pin Gao
Yijun Li
Huimin Zhang
Zhimin Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1167912

2,949 views
2 citations

Original Research

Published on 29 Mar 2023

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer

in Breast Cancer

Ying Jiao
Shiyu Li
Juejun Gong
Kun Zheng
Ya Xie

Frontiers in Oncology

doi 10.3389/fonc.2023.1134149

2,828 views
2 citations

Original Research

Published on 29 Mar 2023

Breast density and estradiol are associated with distinct different expression patterns of metabolic proteins in normal human breast tissue in vivo

in Breast Cancer

Jimmy Ekstrand
Annelie Abrahamsson
Peter Lundberg
Charlotta Dabrosin

Frontiers in Oncology

doi 10.3389/fonc.2023.1128318

2,795 views
2 citations

Original Research

Published on 29 Mar 2023

Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study

in Breast Cancer

Chang-Gen Liu
Yi-Fan Li
Tian-Yi Ma
Meng Lv
Zhi-Dong Lv
Yuan-Yuan Wang
Xiang-Ping Liu
Yan Mao
Hai-Bo Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1130734

3,098 views
8 citations

Original Research

Published on 29 Mar 2023

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer

in Breast Cancer

Kun Sun
Hong Zhu
Weimin Chai
Fuhua Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1153261

3,746 views
7 citations

Original Research

Published on 29 Mar 2023

A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer

in Breast Cancer

Ruhan A
Naoto Kunimura
Shoko Tominaga
Erika Hirata
Shunya Nishioka
Misato Uesugi
Rion Yamazaki
Hideto Ueki
Koichi Kitagawa
Masato Fujisawa

Frontiers in Oncology

doi 10.3389/fonc.2023.1147668

4,494 views
4 citations

Original Research

Published on 28 Mar 2023

Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study

in Breast Cancer

Shengyu Pu
Peiling Xie
Heyan Chen
Yijun Li
Jianjun He
Huimin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.992573

3,457 views
4 citations

Original Research

Published on 28 Mar 2023

Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy

in Breast Cancer

Hongyu Pu
Yunbo Luo
Linxing Zhang
Xin Li
Fangwei Li
Jingtai Chen
Shuangqiang Qian
Yunhui Tang
Xiaobo Zhao
Lingmi Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1112687

2,442 views